Compare REXR’s preferred stocks (REXR.PR.B and REXR.PR.C) to top REIT investment-grade options trading below par. See competitive ratings and metrics.
Predictive Oncology (Nasdaq: POAI), an AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH ...
Predictive Oncology (Nasdaq: POAI) , an AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir ...
Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback